To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF654TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
83 supporting clones for gene ZNF654 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DN999313   .a 1 to 674 9 to 682   tiling clone,   674/682
(98 %)
6 diff
(99.2 %id)
AF543494   .a 8 to 2452 1 to 2446   tiling clone,   2446/2446
(100 %)
8 diff
(99.7 %id)
NM_018293.2   .a 9 to 4965 1 to 4957   RefSeq,   4957/4957
(100 %)
0 diff
(100 %id)
BF749345 breast_normal .a 133 to 678 18 to 563       546/563
(96 %)
10 diff
(98.3 %id)
DA502418 brain .a 155 to 689 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
AK001859 placenta .a 222 to 2373 1 to 2152   tiling clone, available from FLJ,   2152/2152
(100 %)
9 diff
(99.6 %id)
AU135589 placenta .a 223 to 955 2 to 733   capped   732/765
(95 %)
11 diff
(98.6 %id)
CD559672 mixed .a 271 to 916 1 to 651   fully sequenced,   651/651
(100 %)
0 diff
(100 %id)
CD559671 mixed .a 271 to 842 1 to 578   fully sequenced,   578/578
(100 %)
0 diff
(100 %id)
BP380208 uterus .a 309 to 888 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BF868641 lung_tumor .a 406 to 762 355 to 1     Submitted on the opposite strand 355/360
(98 %)
2 diff
(99.5 %id)
BG533365 Liver .a 459 to 1318 1 to 873       873/938
(93 %)
32 diff
(96.6 %id)
CN426865 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 675 to 1371 1 to 697       697/697
(100 %)
2 diff
(99.8 %id)
BP375748 uterus .a 678 to 1249 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BX505107   .a 784 to 1233 1 to 450       450/450
(100 %)
3 diff
(99.4 %id)
CD559516 mixed .a 812 to 1406 609 to 1   fully sequenced,   609/609
(100 %)
2 diff
(99.7 %id)
CD559517 mixed .a 886 to 1406 534 to 1   tiling clone, fully sequenced,   534/534
(100 %)
0 diff
(100 %id)
AU117132 whole embryo, mainly head .a 980 to 1762 2 to 786   capped   785/785
(100 %)
8 diff
(99.0 %id)
DB001642 breast, tumor tissue .a 1043 to 1566 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
Z44023 brain, total brain .a 1214 to 1548 1 to 335       335/335
(100 %)
1 diff
(99.8 %id)
AK024795   .a 1346 to 2585 1 to 1241   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1241/1241
(100 %)
3 diff
(99.8 %id)
BP206224 coronary artery .a 1346 to 1847 1 to 502       502/581
(86 %)
13 diff
(97.8 %id)
BF572460 melanotic melanoma, high MDR, skin .a 1380 to 1882 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
BG258433 embryonal carcinoma, cell line, testis .a 1487 to 2265 1 to 766       766/767
(99 %)
23 diff
(97.1 %id)
CF137267 lymph .a 1538 to 2128 8 to 598       591/598
(98 %)
7 diff
(98.9 %id)
TI_154166642   .a 1538 to 2251 80 to 801       722/785
(91 %)
19 diff
(97.6 %id)
AW962283   .a 1548 to 2114 9 to 571       563/575
(97 %)
22 diff
(96.2 %id)
AA353719   .a 1549 to 1929 11 to 392       382/395
(96 %)
15 diff
(96.3 %id)
AA369529 placenta .a 1676 to 1941 1 to 267       267/267
(100 %)
1 diff
(99.7 %id)
TI_154103190   .a 1693 to 2607 960 to 59   tiling clone,   902/1045
(86 %)
26 diff
(97.6 %id)
DA024295   .a 1824 to 2388 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
AU156155 placenta .a 1836 to 2371 533 to 1       533/567
(94 %)
33 diff
(94.2 %id)
AU144046 whole embryo, mainly head .a 2012 to 2592 577 to 1   tiling clone,   577/577
(100 %)
16 diff
(97.3 %id)
Z40074 brain, total brain .a 2232 to 2579 348 to 1       348/348
(100 %)
3 diff
(99.2 %id)
BX953330   .b-u 1 to 611 1 to 612   tiling clone,   612/612
(100 %)
2 diff
(99.7 %id)
DB149127 thymus .b-u 252 to 804 2 to 555   tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
BG111375 Bone, osteosarcoma, cell line .b-u 1187 to 1906 12 to 725   tiling clone,   714/739
(96 %)
8 diff
(99.0 %id)
DB345980 thymus .b-u 1510 to 2047 540 to 1       540/540
(100 %)
7 diff
(98.8 %id)
DN914118   .b-u 1561 to 2233 8 to 678       671/678
(98 %)
6 diff
(99.2 %id)
CN426866 embryonic stem cells, cell lines H1, H7, andH9 .b-u 1632 to 1901 7 to 276       270/276
(97 %)
3 diff
(99.0 %id)
CK724867 Chondrosarcoma, Left Pubic Bone .b-u 1649 to 2289 642 to 1   tiling clone,   642/642
(100 %)
5 diff
(99.3 %id)
BF436154 pooled .b-u 1723 to 2276 554 to 1       554/554
(100 %)
3 diff
(99.5 %id)
DN914119   .b-u 1752 to 2265 534 to 20   AAA Possibly primed on the genome, locally A rich (22/26 A in genome downstream of last aligned base) 515/515
(100 %)
9 diff
(98.3 %id)
AW339472 carcinoid, lung .b-u 1786 to 2281 496 to 1       496/496
(100 %)
3 diff
(99.4 %id)
TI_151731789   .b-u 1788 to 2297 562 to 53       510/1055
(48 %)
0 diff
(100 %id)
BQ188422 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b-u 1792 to 2297 1 to 506       506/509
(99 %)
8 diff
(98.5 %id)
BE502986 carcinoid, lung .b-u 1800 to 2281 482 to 1       482/482
(100 %)
3 diff
(99.4 %id)
BE349352 malignant melanoma, metastatic to lymphnode, skin .b-u 1817 to 2271 455 to 1       455/455
(100 %)
4 diff
(99.2 %id)
AA831615 germinal center B cell .b-u 1839 to 2291 453 to 2   tiling clone,   452/453
(99 %)
0 diff
(100 %id)
N64143 cochlea, ear .b-u 1846 to 2282 448 to 5       444/450
(98 %)
0 diff
(100 %id)
AW966907   .b-u 1850 to 2460 35 to 649       615/649
(94 %)
6 diff
(99.1 %id)
AA236168 germinal center B cell .b-u 1850 to 2071 1 to 222       222/222
(100 %)
3 diff
(98.7 %id)
N33517 melanocyte .b-u 1865 to 2271 408 to 1       408/409
(99 %)
6 diff
(98.6 %id)
AW966912   .b-u 1866 to 2622 760 to 1     Submitted on the opposite strand 760/762
(99 %)
4 diff
(99.5 %id)
AI572552 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b-u 1874 to 2273 400 to 1       400/400
(100 %)
3 diff
(99.3 %id)
BM930860 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b-u 1908 to 2271 1 to 364   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 364/364
(100 %)
3 diff
(99.2 %id)
AW967533   .b-u 1970 to 2622 655 to 1     Submitted on the opposite strand 655/655
(100 %)
5 diff
(99.3 %id)
AA769226 germinal center B cell .b-u 1976 to 2277 303 to 4   tiling clone,   300/303
(99 %)
0 diff
(100 %id)
BE348919 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b-u 1986 to 2278 292 to 1       292/296
(98 %)
8 diff
(97.3 %id)
AW138341   .b-u 2010 to 2278 279 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 269/269
(100 %)
0 diff
(100 %id)
AA729464 alveolar rhabdomyosarcoma .b-u 2088 to 2401 1 to 316       316/316
(100 %)
5 diff
(98.5 %id)
AA281714 germinal center B cell .b-u 2171 to 2623 455 to 1   tiling clone,   455/455
(100 %)
1 diff
(99.8 %id)
AA236169 germinal center B cell .b-u 2373 to 2623 251 to 1       251/251
(100 %)
0 diff
(100 %id)
BF540959 hypernephroma, Kidney .b-u 2499 to 3170 1 to 666   tiling clone,   666/667
(99 %)
13 diff
(98.1 %id)
AW293870   .b-u 2819 to 3267 1 to 449   tiling clone, Submitted on the opposite strand 449/449
(100 %)
11 diff
(97.6 %id)
BP397364 pancreatic islet .b-u 2973 to 3472 1 to 500   tiling clone, Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
BG574324 breast, mammary adenocarcinoma, cell line .b-u 2980 to 3769 1 to 794   tiling clone,   794/794
(100 %)
11 diff
(98.7 %id)
AI683011 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b-u 3009 to 3490 495 to 14   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 482/482
(100 %)
3 diff
(99.4 %id)
CD357984 Pooled-Skin .b-u 3390 to 4087 1 to 709       709/755
(93 %)
27 diff
(96.5 %id)
AL120354 amygdala .b-u 3395 to 3899 1 to 504       504/504
(100 %)
3 diff
(99.5 %id)
BI870838 adenocarcinoma, cell line, Liver .b-u 3560 to 4347 13 to 802   tiling clone,   790/803
(98 %)
13 diff
(98.4 %id)
TI_57230042   .b-u 3560 to 4347 91 to 880       790/803
(98 %)
13 diff
(98.4 %id)
CD640483 pooled .b-u 3728 to 4441 1 to 714       714/715
(99 %)
6 diff
(99.2 %id)
TI_154046391   .b-u 3756 to 4645 973 to 85   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 889/1009
(88 %)
8 diff
(99.3 %id)
BG925148 cartilage .b-u 3826 to 4460 85 to 719       635/652
(97 %)
6 diff
(99.1 %id)
TI_149288159   .b-u 3879 to 4645 843 to 84   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 760/955
(79 %)
11 diff
(98.9 %id)
CA412309 Chondrosarcoma Grade II, Left Pelvis .b-u 3941 to 4645 723 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 705/705
(100 %)
0 diff
(100 %id)
BM970226 lung .b-u 3946 to 4645 718 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 700/700
(100 %)
1 diff
(99.9 %id)
AI660684 colon, colonic mucosa from 5 ulcerative colitispatients .b-u 4073 to 4652 581 to 2 exact tiling clone,   580/581
(99 %)
0 diff
(100 %id)
BQ189183 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b-u 4111 to 4399 1 to 289   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 289/289
(100 %)
0 diff
(100 %id)
AW300274 Kidney .b-u 4198 to 4602 405 to 1       405/405
(100 %)
0 diff
(100 %id)
AL135505 melanoma (MeWo cell line) .b-u 4217 to 4648 102 to 527       426/530
(80 %)
17 diff
(96.8 %id)
AW151179 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b-u 4229 to 4645 429 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 417/417
(100 %)
1 diff
(99.8 %id)
AI453452 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b-u 4251 to 4645 425 to 31   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 395/395
(100 %)
3 diff
(99.3 %id)
AI215946   .b-u 4351 to 4648 300 to 4       297/300
(99 %)
0 diff
(100 %id)
AW316555 brain, three pooled meningiomas .b-u 4354 to 4647 294 to 1       294/294
(100 %)
1 diff
(99.7 %id)
AA767937 germinal center B cell .b-u 4358 to 4645 314 to 27   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 288/288
(100 %)
0 diff
(100 %id)
D62603   .b-u 4395 to 4645 1 to 255       255/255
(100 %)
12 diff
(95.3 %id)
BQ216287 embryonal carcinoma, cell line, testis .b-u 4417 to 4645 1 to 230   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 230/230
(100 %)
1 diff
(99.6 %id)
AV709143 adrenal gland Gene ZNF654, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C